Medipharm Labs Finally Appoints Replacement CFO

Medipharm Labs (TSX: LABS) this morning finally appointed a new chief financial officer, more than two months after the announced departure of former CFO Bobby Kwon. The company will see Greg Hunter take on the role, effective February 8, 2021.

Hunter most recently served as CFO of Medical Pharmacies Group Ltd, a pharmacy and medical equipment manufacturer in Canada. Prior to that, he held several senior management roles with Baxter International, including the role of CFO for the firms Canadian subsidiary.

In terms of education, Hunter holds an MBA from McMaster University, as well as an Honors B.Sc. in microbiology and immunology from the University of Western Ontario, while also being a CPA.

The company has yet to find a permanent replacement for the role of CEO, following the departure of Pat McCutcheon from the position in December 2020, following poor financial results released two weeks prior. President Keith Strachan is currently filling that role on an interim basis.

Medipharm Labs last traded at $0.63 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Rough Week In Cannabis Sector Capped With Gut Punch From Ontario

This first week of April has been the never-ending week for the cannabis industry that...

Friday, April 3, 2020, 03:24:27 PM

MediPharm Labs Revenues Continue To Decline, Posts Negative Gross Margin

Medipharm Labs (TSX: LABS) this morning continued to show its desperate need for effective leadership....

Monday, August 16, 2021, 08:52:05 AM

Medipharm Labs Announces White Label Agreement, Provides No Details

Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its...

Monday, May 4, 2020, 08:24:41 AM

MediPharm Labs: Canaccord Resumes Coverage, Issues $2.25 Price Target

As a follow up to the earlier covered resumption of coverage by Canaccord Genuity on...

Monday, July 6, 2020, 04:53:00 PM

Medipharm Labs Sees Revenues Crater 65.8% Quarter Over Quarter

Medipharm Labs (TSX: LABS) has seen its revenues absolutely implode in a single quarter. The...

Thursday, June 18, 2020, 08:35:37 AM